| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 416.396 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 412.982 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 374.88 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 457.058 | 91 |
| GSM780720 | Untreated after 4 days (C2_2) | 470.846 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 410.37 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 407.875 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 416.18 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 490.795 | 91 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 452.004 | 91 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 452.115 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 561.859 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 378.711 | 89 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 401.243 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 469.974 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 446.03 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 443.669 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 425.482 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 518.88 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 437.972 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 480.689 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 486.405 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 422.001 | 90 |